Related Experiment Videos

[HbA1 as a parameter of the progression of diabetic retinopathy]

Klinische Monatsblatter Fur Augenheilkunde
|November 1, 1982
PubMed

Insights

Glycated hemoglobin (HbA1) levels significantly impact diabetic retinopathy progression. Tightly controlled HbA1 below 8% stabilizes retinopathy, while higher levels indicate worsening disease, even with laser treatment.

Area of Science:

  • Endocrinology
  • Ophthalmology

Background:

  • Diabetic retinopathy is a major complication of diabetes mellitus.
  • Glycated hemoglobin (HbA1) is a key indicator of long-term glycemic control.

Purpose of the Study:

  • To investigate the relationship between HbA1 levels and the progression of diabetic retinopathy in juvenile and adult diabetics.
  • To assess the efficacy of laser treatment in relation to HbA1 control.

Main Methods:

  • HbA1 levels were measured every four weeks in 12 juvenile and 10 adult diabetics.
  • The progression of diabetic retinopathy was monitored concurrently.
  • Laser treatment was administered as needed.

Main Results:

  • Juvenile diabetics with HbA1 < 8% showed stable retinopathy.
  • Moderate retinopathy progression (HbA1 8-10%) was slowed by laser treatment.
  • Marked progression unresponsive to laser therapy was seen with HbA1 > 10%.

Conclusions:

  • Strict glycemic control (HbA1 < 8%) is crucial for preventing diabetic retinopathy progression.
  • Laser therapy is less effective in patients with poor glycemic control (HbA1 > 10%).
  • Adult-onset diabetes progression mirrors juvenile patterns, while elderly diabetics show less tendency.

Related Concept Videos